Brisbane, Australia and Cambridge, UK – 29 September 2020 – 4am Software Pty Ltd., announces its appointment as distributor of Cresset computational...

An introduction to Python Extensions in Flareâ„¢ Learn how to access additional functionality in our structure-based design platform, Flare,...

Sneak peek at Sparkâ„¢ V10.6  With the upcoming release of Spark V10.6, Giovanna Tedesco, Head of Products, presents some of the new...

Sparkâ„¢ V10.6 release: New docking functionality and improved search methods for refined molecule design Giovanna Tedesco, Head of Products,...

Cambridge, UK – 18 November 2020 – Cresset, innovative provider of outstanding software for molecule discovery and design, announces...

CEO’s end of year message Robert Scoffin, CEO, reviews 2020 – from our continued growth, scientific developments, software and...

Computational methods play an integral role through all stages of the drug discovery workflow, accelerating the identification of hit compounds...

KNIME nodes and Pipeline Pilot components V2.6 released  Version V2.6 of Cresset workflow components for the KNIMEâ„¢ and Pipeline Pilotâ...

Streamline design for covalent inhibitors  Medicinal chemistry has renewed its interest in targeted covalent inhibitors. Explore how the...

Case study: Investigating the SAR of RIPK1 inhibitors  Understanding SAR is fundamental in many aspects of drug discovery, from exploring...

Building a blood-brain barrier penetration model in Flareâ„¢  We show how the enhanced QSAR modeling capabilities in Flare V5 (due...

Cresset User Group Meeting: June 16th and 17th  Hear Cresset scientists present our latest science, and showcase upcoming solutions to...

The Cresset User Group Meeting was held virtually again this year. Thank you to everyone who attended. Below are summaries of the presentations...

High-throughput virtual screening is a powerful computational technique for exploring new chemical space, discovering diverse chemotypes...

Flare V5 released: Innovative science and synergy between ligand and structure-based methods  Flareâ„¢ V5 is now available....

Cambridge, UK – 14 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, announces the release...

Cambridge, UK – 21 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce...

Flareâ„¢ FEP: Competitively combining speed and accuracy with ease of use  Free Energy Perturbation (FEP) calculations can...

Drug discovery is an increasingly complex process with significant time and costs needed to develop a new drug from hypothesis to market. As a result,...

The search for a better charge model  Protein-ligand binding affinity is one of the most useful metrics for predicting drug activity. We...

Cambridge, UK – 14 September 2021 – Cresset Discovery Services, provider of contract research services for early phase of drug discovery, has...

Completing the DMTA cycle with the release of Torx Testâ„¢ and Torx Analyzeâ„¢ Our partner Torx Software is delighted to announce...

Prioritize the best molecules in drug discovery using Sparkâ„¢ and Flareâ„¢ FEP In this case study, we investigate the ability of a workflow...

  Robust QSAR models enable computational and medicinal chemists to accurately predict the biological activity and ADMET properties of...

As a specialist CADD CRO, Cresset Discovery applies sophisticated computational approaches and extensive cross-industry expertise to support...

Building predictive QSAR models with Flareâ„¢ to prioritize the best molecules  Robust QSAR models enable computational...

CEO’s end of year message 2021 Robert Scoffin, CEO, reviews 2021 – from our continued growth and scientific...

Globachem renews contract with Cresset Discovery Cambridge, UK – 08 February 2022 – Cresset Discovery, provider of contract consulting for...

Cambridge, UK – 21 June 2022 – Cresset, innovative provider of outstanding software for molecule discovery and design, announces the release...

We are proud to support students and academic researchers at all stages of their careers, by providing flexible licensing options for molecular...

Cambridge, UK – 17 January, 2023 – Cresset Discovery, provider of molecular modeling expertise for drug discovery, is collaborating with the...